Pulmonary fibrosis secondary to COVID-19: a call to arms?
Paolo Spagnolo(University of Padua), Toby M. Maher(University of Southern California)
Cited by 498
Related Papers
PD-1 up-regulation on CD4 <sup>+</sup> T cells promotes pulmonary fibrosis through STAT3-mediated IL-17A and TGF-β1 production
|Science Translational Medicine|2018|364
Genetic variants associated with susceptibility to idiopathic pulmonary fibrosis in people of European ancestry: a genome-wide association study
|The Lancet Respiratory Medicine|2017|299
Monocyte Count as a Prognostic Biomarker in Patients with Idiopathic Pulmonary Fibrosis
|American Journal of Respiratory and Critical Care Medicine|2021|198
Validation of a 52-gene risk profile for outcome prediction in patients with idiopathic pulmonary fibrosis: an international, multicentre, cohort study
|The Lancet Respiratory Medicine|2017|191
Nerandomilast in Patients with Idiopathic Pulmonary Fibrosis
|New England Journal of Medicine|2025|159